nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—MAOA—Parkinson's disease	0.391	0.483	CbGaD
Almotriptan—CYP2E1—Parkinson's disease	0.241	0.298	CbGaD
Almotriptan—CYP2D6—Parkinson's disease	0.177	0.219	CbGaD
Almotriptan—MAOA—locus ceruleus—Parkinson's disease	0.00581	0.134	CbGeAlD
Almotriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.00373	0.0864	CbGeAlD
Almotriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00362	0.0837	CbGeAlD
Almotriptan—MAOA—nerve—Parkinson's disease	0.00174	0.0402	CbGeAlD
Almotriptan—Melatonin—NQO2—Parkinson's disease	0.00138	0.153	CrCbGaD
Almotriptan—MAOA—hindbrain—Parkinson's disease	0.0013	0.0301	CbGeAlD
Almotriptan—Naratriptan—MAOA—Parkinson's disease	0.00107	0.118	CrCbGaD
Almotriptan—HTR1B—brainstem—Parkinson's disease	0.00101	0.0234	CbGeAlD
Almotriptan—HTR1D—brainstem—Parkinson's disease	0.000978	0.0226	CbGeAlD
Almotriptan—HTR1B—forebrain—Parkinson's disease	0.000975	0.0226	CbGeAlD
Almotriptan—FMO3—head—Parkinson's disease	0.000952	0.022	CbGeAlD
Almotriptan—HTR1D—forebrain—Parkinson's disease	0.000944	0.0219	CbGeAlD
Almotriptan—FMO3—nervous system—Parkinson's disease	0.000902	0.0209	CbGeAlD
Almotriptan—Rizatriptan—MAOA—Parkinson's disease	0.000886	0.0979	CrCbGaD
Almotriptan—FMO3—central nervous system—Parkinson's disease	0.000869	0.0201	CbGeAlD
Almotriptan—HTR1B—cardiovascular system—Parkinson's disease	0.000825	0.0191	CbGeAlD
Almotriptan—MAOA—embryo—Parkinson's disease	0.000813	0.0188	CbGeAlD
Almotriptan—Zolmitriptan—MAOA—Parkinson's disease	0.00081	0.0896	CrCbGaD
Almotriptan—Naratriptan—HTR1A—Parkinson's disease	0.000807	0.0893	CrCbGaD
Almotriptan—HTR1D—cardiovascular system—Parkinson's disease	0.000798	0.0185	CbGeAlD
Almotriptan—CYP2D6—hindbrain—Parkinson's disease	0.000772	0.0179	CbGeAlD
Almotriptan—MAOA—brainstem—Parkinson's disease	0.000745	0.0172	CbGeAlD
Almotriptan—MAOA—forebrain—Parkinson's disease	0.000719	0.0166	CbGeAlD
Almotriptan—FMO3—brain—Parkinson's disease	0.00069	0.016	CbGeAlD
Almotriptan—Rizatriptan—HTR1A—Parkinson's disease	0.000669	0.074	CrCbGaD
Almotriptan—HTR1B—midbrain—Parkinson's disease	0.000644	0.0149	CbGeAlD
Almotriptan—HTR1B—spinal cord—Parkinson's disease	0.000628	0.0145	CbGeAlD
Almotriptan—HTR1D—midbrain—Parkinson's disease	0.000623	0.0144	CbGeAlD
Almotriptan—Zolmitriptan—HTR1A—Parkinson's disease	0.000612	0.0677	CrCbGaD
Almotriptan—MAOA—cardiovascular system—Parkinson's disease	0.000608	0.0141	CbGeAlD
Almotriptan—Sumatriptan—MAOA—Parkinson's disease	0.000591	0.0653	CrCbGaD
Almotriptan—HTR1B—head—Parkinson's disease	0.000558	0.0129	CbGeAlD
Almotriptan—HTR1D—head—Parkinson's disease	0.000541	0.0125	CbGeAlD
Almotriptan—HTR1B—nervous system—Parkinson's disease	0.000529	0.0123	CbGeAlD
Almotriptan—MAOA—medulla oblongata—Parkinson's disease	0.000519	0.012	CbGeAlD
Almotriptan—HTR1D—nervous system—Parkinson's disease	0.000513	0.0119	CbGeAlD
Almotriptan—HTR1B—central nervous system—Parkinson's disease	0.00051	0.0118	CbGeAlD
Almotriptan—HTR1D—central nervous system—Parkinson's disease	0.000493	0.0114	CbGeAlD
Almotriptan—MAOA—midbrain—Parkinson's disease	0.000475	0.011	CbGeAlD
Almotriptan—Eletriptan—HTR7—Parkinson's disease	0.000471	0.0521	CrCbGaD
Almotriptan—MAOA—spinal cord—Parkinson's disease	0.000463	0.0107	CbGeAlD
Almotriptan—CYP2E1—cardiovascular system—Parkinson's disease	0.000456	0.0106	CbGeAlD
Almotriptan—Sumatriptan—HTR1A—Parkinson's disease	0.000446	0.0494	CrCbGaD
Almotriptan—CYP2D6—brainstem—Parkinson's disease	0.000443	0.0102	CbGeAlD
Almotriptan—CYP2D6—forebrain—Parkinson's disease	0.000427	0.00989	CbGeAlD
Almotriptan—MAOA—head—Parkinson's disease	0.000412	0.00953	CbGeAlD
Almotriptan—HTR1B—brain—Parkinson's disease	0.000405	0.00937	CbGeAlD
Almotriptan—HTR1D—brain—Parkinson's disease	0.000392	0.00907	CbGeAlD
Almotriptan—MAOA—nervous system—Parkinson's disease	0.00039	0.00903	CbGeAlD
Almotriptan—CYP2E1—medulla oblongata—Parkinson's disease	0.00039	0.00902	CbGeAlD
Almotriptan—Sumatriptan—DRD2—Parkinson's disease	0.000379	0.0419	CrCbGaD
Almotriptan—MAOA—central nervous system—Parkinson's disease	0.000376	0.0087	CbGeAlD
Almotriptan—MAOA—cerebellum—Parkinson's disease	0.000367	0.0085	CbGeAlD
Almotriptan—Eletriptan—HTR1A—Parkinson's disease	0.000361	0.0399	CrCbGaD
Almotriptan—CYP2E1—spinal cord—Parkinson's disease	0.000348	0.00805	CbGeAlD
Almotriptan—CYP2E1—head—Parkinson's disease	0.000309	0.00715	CbGeAlD
Almotriptan—MAOA—brain—Parkinson's disease	0.000298	0.00691	CbGeAlD
Almotriptan—CYP2E1—nervous system—Parkinson's disease	0.000293	0.00678	CbGeAlD
Almotriptan—CYP2E1—central nervous system—Parkinson's disease	0.000282	0.00653	CbGeAlD
Almotriptan—CYP2E1—cerebellum—Parkinson's disease	0.000276	0.00638	CbGeAlD
Almotriptan—CYP2C8—brain—Parkinson's disease	0.000266	0.00616	CbGeAlD
Almotriptan—CYP2D6—head—Parkinson's disease	0.000245	0.00566	CbGeAlD
Almotriptan—CYP3A4—nervous system—Parkinson's disease	0.000236	0.00546	CbGeAlD
Almotriptan—CYP2D6—nervous system—Parkinson's disease	0.000232	0.00537	CbGeAlD
Almotriptan—CYP3A4—central nervous system—Parkinson's disease	0.000227	0.00525	CbGeAlD
Almotriptan—CYP2E1—brain—Parkinson's disease	0.000224	0.00518	CbGeAlD
Almotriptan—CYP2D6—central nervous system—Parkinson's disease	0.000223	0.00517	CbGeAlD
Almotriptan—CYP2D6—cerebellum—Parkinson's disease	0.000218	0.00505	CbGeAlD
Almotriptan—Eletriptan—CYP2D6—Parkinson's disease	0.000217	0.024	CrCbGaD
Almotriptan—Sumatriptan—ABCB1—Parkinson's disease	0.000191	0.0211	CrCbGaD
Almotriptan—CYP2D6—brain—Parkinson's disease	0.000177	0.0041	CbGeAlD
Almotriptan—Eletriptan—ABCB1—Parkinson's disease	0.000155	0.0171	CrCbGaD
Almotriptan—MAOA—Metabolism—MAOB—Parkinson's disease	3.26e-05	0.000236	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GRM5—Parkinson's disease	3.24e-05	0.000234	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—FBP1—Parkinson's disease	3.24e-05	0.000234	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—DBH—Parkinson's disease	3.24e-05	0.000234	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GBA—Parkinson's disease	3.24e-05	0.000234	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GFAP—Parkinson's disease	3.21e-05	0.000232	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GRM5—Parkinson's disease	3.17e-05	0.000229	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GCH1—Parkinson's disease	3.14e-05	0.000227	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—MTHFR—Parkinson's disease	3.11e-05	0.000225	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TALDO1—Parkinson's disease	3.1e-05	0.000224	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—OMD—Parkinson's disease	3.1e-05	0.000224	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.06e-05	0.000221	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.04e-05	0.00022	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.03e-05	0.000219	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ND3—Parkinson's disease	3.03e-05	0.000219	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.03e-05	0.000219	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—EDN1—Parkinson's disease	3.02e-05	0.000218	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.01e-05	0.000218	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3e-05	0.000217	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—EDN1—Parkinson's disease	2.95e-05	0.000214	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	2.94e-05	0.000212	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—APOE—Parkinson's disease	2.89e-05	0.000209	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—OMD—Parkinson's disease	2.85e-05	0.000206	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.85e-05	0.000206	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGF20—Parkinson's disease	2.84e-05	0.000205	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.83e-05	0.000205	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GCH1—Parkinson's disease	2.8e-05	0.000203	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—FBP1—Parkinson's disease	2.8e-05	0.000202	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—DBH—Parkinson's disease	2.8e-05	0.000202	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GBA—Parkinson's disease	2.8e-05	0.000202	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.8e-05	0.000202	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGF20—Parkinson's disease	2.78e-05	0.000201	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.76e-05	0.000199	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	2.75e-05	0.000199	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	2.74e-05	0.000198	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.73e-05	0.000197	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.7e-05	0.000195	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	2.7e-05	0.000195	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	2.68e-05	0.000194	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	2.64e-05	0.000191	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.59e-05	0.000187	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.58e-05	0.000186	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MCCC1—Parkinson's disease	2.57e-05	0.000186	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ND3—Parkinson's disease	2.57e-05	0.000186	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INSR—Parkinson's disease	2.54e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.53e-05	0.000183	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.5e-05	0.000181	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DBH—Parkinson's disease	2.5e-05	0.000181	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GBA—Parkinson's disease	2.5e-05	0.000181	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INSR—Parkinson's disease	2.49e-05	0.00018	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—INS—Parkinson's disease	2.47e-05	0.000179	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP2D6—Parkinson's disease	2.42e-05	0.000175	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.41e-05	0.000175	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—OMD—Parkinson's disease	2.41e-05	0.000175	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGB—Parkinson's disease	2.4e-05	0.000174	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	2.4e-05	0.000173	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	2.39e-05	0.000173	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CTGF—Parkinson's disease	2.38e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000172	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	2.35e-05	0.00017	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGB—Parkinson's disease	2.35e-05	0.00017	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.35e-05	0.00017	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	2.34e-05	0.000169	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	2.31e-05	0.000167	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	2.31e-05	0.000167	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GBA—Parkinson's disease	2.3e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.3e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DBH—Parkinson's disease	2.3e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.29e-05	0.000165	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	2.26e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.24e-05	0.000162	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	2.24e-05	0.000162	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP2E1—Parkinson's disease	2.22e-05	0.00016	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NQO1—Parkinson's disease	2.19e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	2.19e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.18e-05	0.000158	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TH—Parkinson's disease	2.16e-05	0.000156	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	2.09e-05	0.000151	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYCS—Parkinson's disease	2.07e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—DDC—Parkinson's disease	2.05e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	2.04e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	2.02e-05	0.000146	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	2.02e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MAOB—Parkinson's disease	2e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ND3—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.97e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GBA—Parkinson's disease	1.95e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.95e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DBH—Parkinson's disease	1.95e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTA4—Parkinson's disease	1.94e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.91e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—OMD—Parkinson's disease	1.86e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.86e-05	0.000135	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—COMT—Parkinson's disease	1.84e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DDC—Parkinson's disease	1.83e-05	0.000133	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTP1—Parkinson's disease	1.83e-05	0.000132	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HMOX1—Parkinson's disease	1.8e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.77e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	1.75e-05	0.000126	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.73e-05	0.000125	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCB1—Parkinson's disease	1.73e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MAOB—Parkinson's disease	1.73e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.71e-05	0.000124	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.69e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DDC—Parkinson's disease	1.69e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.69e-05	0.000122	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTM1—Parkinson's disease	1.68e-05	0.000121	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.66e-05	0.00012	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.65e-05	0.000119	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.64e-05	0.000118	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.62e-05	0.000117	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GPX1—Parkinson's disease	1.61e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.56e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.54e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DBH—Parkinson's disease	1.5e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.5e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GBA—Parkinson's disease	1.5e-05	0.000109	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.49e-05	0.000107	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—Parkinson's disease	1.48e-05	0.000107	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.47e-05	0.000106	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.46e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.43e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DDC—Parkinson's disease	1.43e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.42e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.42e-05	0.000102	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.39e-05	0.0001	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—Parkinson's disease	1.38e-05	9.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.35e-05	9.75e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.34e-05	9.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.33e-05	9.63e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TH—Parkinson's disease	1.32e-05	9.58e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.32e-05	9.52e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.29e-05	9.32e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.28e-05	9.29e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.27e-05	9.2e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.26e-05	9.12e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.21e-05	8.78e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.2e-05	8.69e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—INS—Parkinson's disease	1.18e-05	8.53e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.18e-05	8.5e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.16e-05	8.4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.15e-05	8.29e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TH—Parkinson's disease	1.15e-05	8.28e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.14e-05	8.27e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—COMT—Parkinson's disease	1.13e-05	8.14e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.13e-05	8.14e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	1.12e-05	8.13e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.12e-05	8.11e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.12e-05	8.09e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.11e-05	7.99e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DDC—Parkinson's disease	1.1e-05	7.97e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	1.1e-05	7.96e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.1e-05	7.95e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.06e-05	7.67e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.05e-05	7.58e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.04e-05	7.53e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.04e-05	7.5e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.04e-05	7.49e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.03e-05	7.45e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TH—Parkinson's disease	1.02e-05	7.39e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—Parkinson's disease	9.87e-06	7.13e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYCS—Parkinson's disease	9.81e-06	7.09e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—COMT—Parkinson's disease	9.74e-06	7.04e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—Parkinson's disease	9.69e-06	7.01e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MAOA—Parkinson's disease	9.67e-06	6.99e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	9.65e-06	6.97e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—Parkinson's disease	9.56e-06	6.91e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NQO1—Parkinson's disease	9.54e-06	6.9e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TH—Parkinson's disease	9.4e-06	6.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.37e-06	6.78e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.28e-06	6.71e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—Parkinson's disease	9.17e-06	6.63e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—Parkinson's disease	9.11e-06	6.58e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYCS—Parkinson's disease	9.03e-06	6.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	8.94e-06	6.46e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—Parkinson's disease	8.91e-06	6.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CTGF—Parkinson's disease	8.77e-06	6.34e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—COMT—Parkinson's disease	8.69e-06	6.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—Parkinson's disease	8.65e-06	6.25e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MAOA—Parkinson's disease	8.63e-06	6.24e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—Parkinson's disease	8.53e-06	6.17e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—Parkinson's disease	8.53e-06	6.17e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—Parkinson's disease	8.48e-06	6.13e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	8.37e-06	6.05e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	8.32e-06	6.02e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	8.2e-06	5.93e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—Parkinson's disease	8.19e-06	5.92e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	8.17e-06	5.91e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	8.15e-06	5.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NQO1—Parkinson's disease	8.08e-06	5.84e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—COMT—Parkinson's disease	7.99e-06	5.78e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TH—Parkinson's disease	7.96e-06	5.76e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.96e-06	5.75e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—Parkinson's disease	7.95e-06	5.75e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.94e-06	5.74e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—Parkinson's disease	7.87e-06	5.69e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.85e-06	5.67e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	7.7e-06	5.56e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYCS—Parkinson's disease	7.65e-06	5.53e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—Parkinson's disease	7.61e-06	5.5e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	7.54e-06	5.45e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—Parkinson's disease	7.53e-06	5.44e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—Parkinson's disease	7.33e-06	5.3e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—Parkinson's disease	7.31e-06	5.29e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—Parkinson's disease	7.24e-06	5.24e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—Parkinson's disease	7.02e-06	5.08e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—Parkinson's disease	7e-06	5.06e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.9e-06	4.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—COMT—Parkinson's disease	6.77e-06	4.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.77e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—Parkinson's disease	6.74e-06	4.87e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MAOA—Parkinson's disease	6.72e-06	4.86e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—Parkinson's disease	6.65e-06	4.81e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—Parkinson's disease	6.54e-06	4.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—Parkinson's disease	6.46e-06	4.67e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—Parkinson's disease	6.38e-06	4.61e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.31e-06	4.56e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—Parkinson's disease	6.26e-06	4.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.24e-06	4.51e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—Parkinson's disease	6.19e-06	4.48e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TH—Parkinson's disease	6.15e-06	4.44e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—Parkinson's disease	6.02e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.93e-06	4.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.9e-06	4.27e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—Parkinson's disease	5.59e-06	4.04e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—Parkinson's disease	5.47e-06	3.96e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—COMT—Parkinson's disease	5.23e-06	3.78e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.2e-06	3.76e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.19e-06	3.75e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—Parkinson's disease	5.14e-06	3.72e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.13e-06	3.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—Parkinson's disease	5.1e-06	3.68e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.92e-06	3.56e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	4.91e-06	3.55e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	4.81e-06	3.48e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.78e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.58e-06	3.31e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—Parkinson's disease	4.35e-06	3.15e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.22e-06	3.05e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—Parkinson's disease	3.93e-06	2.84e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—Parkinson's disease	3.36e-06	2.43e-05	CbGpPWpGaD
